Evidence map›Paper›PMID 32243820›Full record

ArticleAmerican journal of human genetics2020

Genotyping Array Design and Data Quality Control in the Million Veteran Program.

Haley Hunter-Zinck, Yunling Shi, Man Li, Bryan R Gorman, Sun-Gou Ji, Ning Sun, Teresa Webster, Andrew Liem, Paul Hsieh, Poornima Devineni and 23 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03170362 (PRIME Care), which is not on this map. Cited by 141 papers, 23 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 23 pooled it
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03170362 nacompletednot on this map

PRIME Care (PRecision Medicine In MEntal Health Care)

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2017 to 2022Enrolled1,944ConditionsMajor DepressionArmsPharmacogenetic Test
3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 23 syntheses or guidelines pooled it, 214 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Multi-ancestry genome-wide association meta-analysis of buprenorphine treatment response.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 9 institutions in 1 country.

Haley Hunter-ZinckVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Yunling ShiVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Man LiVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Bryan R GormanVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA; Booz Allen Hamilton, McLean, VA 22102, USA.
Sun-Gou JiVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA; Seven Bridges, Boston, MA 02129, USA.
Ning SunVA Cooperative Studies Program, VA Connecticut Healthcare System, West Haven, CT 06516, USA; Yale University School of Medicine, New Haven, CT 06510, USA.
Teresa WebsterThermo Fisher Scientific, Santa Clara, CA 95054, USA.
Andrew LiemVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA; Booz Allen Hamilton, McLean, VA 22102, USA.
Paul HsiehVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Poornima DevineniVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Purushotham KarnamVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Xin GongVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Lakshmi RadhakrishnanThermo Fisher Scientific, Santa Clara, CA 95054, USA.
Jeanette SchmidtThermo Fisher Scientific, Santa Clara, CA 95054, USA.
Themistocles L AssimesVA Palo Alto Health Care System, Palo Alto, CA 94304, USA; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jie HuangVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Cuiping PanVA Palo Alto Health Care System, Palo Alto, CA 94304, USA; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Donald HumphriesVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Mary BrophyVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Jennifer MoserOffice of Research and Development, Veterans Health Administration, Washington DC 20571, USA.
Sumitra MuralidharOffice of Research and Development, Veterans Health Administration, Washington DC 20571, USA.
Grant D HuangOffice of Research and Development, Veterans Health Administration, Washington DC 20571, USA.
Ronald PrzygodzkiOffice of Research and Development, Veterans Health Administration, Washington DC 20571, USA.
John ConcatoVA Cooperative Studies Program, VA Connecticut Healthcare System, West Haven, CT 06516, USA; Yale University School of Medicine, New Haven, CT 06510, USA.
John M GazianoVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA; Department of Medicine, Brigham and Women's Hospital and Harvard School of Medicine, Boston, MA 02115, USA.
Joel GelernterVA Cooperative Studies Program, VA Connecticut Healthcare System, West Haven, CT 06516, USA; Yale University School of Medicine, New Haven, CT 06510, USA.
Christopher J O'DonnellVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA.
Elizabeth R HauserDurham VA Health System, Durham, NC 27705, USA; Department of Medicine, Duke University, Durham, NC 27617, USA.
Hongyu ZhaoVA Cooperative Studies Program, VA Connecticut Healthcare System, West Haven, CT 06516, USA; Yale University School of Medicine, New Haven, CT 06510, USA.
Timothy J O'LearyOffice of Research and Development, Veterans Health Administration, Washington DC 20571, USA.
VA Million Veteran Program
Philip S TsaoVA Palo Alto Health Care System, Palo Alto, CA 94304, USA; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Saiju PyarajanVA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA 02130, USA; Department of Medicine, Brigham and Women's Hospital and Harvard School of Medicine, Boston, MA 02115, USA. Electronic address: saiju.pyarajan@va.gov.
VA Boston Healthcare System · USVA Office of Research and Development · USYale University · USThermo Fisher Scientific (United States) · USVA Palo Alto Health Care System · USBooz Allen Hamilton (United States) · USBrigham and Women's Hospital · USDuke University · USUniversity of Utah · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Racial and Ethnic Diversity in Human Extracellular RNAU01HL126495 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FREEDMAN, JANE E, GERSTEIN, MARK BENDER · 2014 to 2018
$3.4M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

The Million Veteran Program (MVP), initiated by the Department of Veterans Affairs (VA), aims to collect biosamples with consent from at least one million veterans. Presently, blood samples have been collected from over 800,000 enrolled participants. The size and diversity of the MVP cohort, as well as the availability of extensive VA electronic health records, make it a promising resource for precision medicine. MVP is conducting array-based genotyping to provide a genome-wide scan of the entire cohort, in parallel with whole-genome sequencing, methylation, and other 'omics assays. Here, we present the design and performance of the MVP 1.0 custom Axiom array, which was designed and developed as a single assay to be used across the multi-ethnic MVP cohort. A unified genetic quality-control analysis was developed and conducted on an initial tranche of 485,856 individuals, leading to a high-quality dataset of 459,777 unique individuals. 668,418 genetic markers passed quality control and showed high-quality genotypes not only on common variants but also on rare variants. We confirmed that, with non-European individuals making up nearly 30%, MVP's substantial ancestral diversity surpasses that of other large biobanks. We also demonstrated the quality of the MVP dataset by replicating established genetic associations with height in European Americans and African Americans ancestries. This current dataset has been made available to approved MVP researchers for genome-wide association studies and other downstream analyses. Further data releases will be available for analysis as recruitment at the VA continues and the cohort expands both in size and diversity.

Indexed as

AgedAged, 80 and overCohort StudiesEthnicityFemaleGenetic MarkersGenome-Wide Association StudyGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotidePrecision MedicineQuality ControlVeteransWhole Genome SequencingGenetic Markersbiobankclinical variantsgenetic ancestrygenetic relatednessgenotype dataGWASMillion Veteran Programquality controlSNP array designVA

Identifiers

PMID32243820
PMCPMC7118558
OpenAlexW3014786661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.